Stockreport

Opiant Pharmaceuticals: Nano-Cap Buyout With Interesting CVR Thrown In [Seeking Alpha]

Opiant Pharmaceuticals, Inc.  (OPNT) 
Last opiant pharmaceuticals, inc. earnings: 3/4 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.opiant.com/investor-overview
PDF NewGig86/iStock via Getty ImagesOpiant Pharmaceuticals, Inc. (NASDAQ:OPNTOTCPK:INVVYto $10 per share. Opiant is trading at $20.21, meaning you only pay $0.21 for the opt [Read more]